226 related articles for article (PubMed ID: 21053359)
1. PRL-3 phosphatase and cancer metastasis.
Al-Aidaroos AQ; Zeng Q
J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
[TBL] [Abstract][Full Text] [Related]
2. PRL-3: a metastasis-associated phosphatase in search of a function.
Bessette DC; Wong PC; Pallen CJ
Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
[TBL] [Abstract][Full Text] [Related]
3. PRL PTPs: mediators and markers of cancer progression.
Bessette DC; Qiu D; Pallen CJ
Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
[TBL] [Abstract][Full Text] [Related]
4. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of the PRL phosphatases.
Rios P; Li X; Köhn M
FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
[TBL] [Abstract][Full Text] [Related]
6. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
7. PRL-3 phosphatase is implicated in ovarian cancer growth.
Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
[TBL] [Abstract][Full Text] [Related]
8. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H
Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591
[TBL] [Abstract][Full Text] [Related]
9. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
[TBL] [Abstract][Full Text] [Related]
10. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
[TBL] [Abstract][Full Text] [Related]
11. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
12. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
[TBL] [Abstract][Full Text] [Related]
13. Targeting PRL phosphatases in hematological malignancies.
Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
[TBL] [Abstract][Full Text] [Related]
14. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.
Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ
Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase of regenerating liver-3: a novel and promising marker in human endometriosis.
Ruan F; Lin J; Wu RJ; Xu KH; Zhang XM; Zhou CY; Huang XF
Fertil Steril; 2010 Nov; 94(6):1980-4. PubMed ID: 20045518
[TBL] [Abstract][Full Text] [Related]
16. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
17. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.
Rubio T; Köhn M
Biochem Soc Trans; 2016 Oct; 44(5):1305-1312. PubMed ID: 27911713
[TBL] [Abstract][Full Text] [Related]
18. Targeting phosphatases of regenerating liver (PRLs) in cancer.
Wei M; Korotkov KV; Blackburn JS
Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH
Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571
[TBL] [Abstract][Full Text] [Related]
20. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
